Sarcopenic obesity in fatty liver

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283 · see citing works

EASL Clinical Practice Guidelines on nutrition in chronic liver disease

Merli, M., Berzigotti, A., Zelber-Sagi, S., Dasarathy, S., Montagnese, S., Genton, L., Plauth, M., & Parés, A. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.024 · Cited by 1,130 · see citing works

Muscle Wasting Is Associated With Mortality in Patients With Cirrhosis

Montaño‐Loza, A. J., Meza–Junco, J., Prado, C. M. M., Lieffers, J. R. L., Baracos, V. E., Bain, V. G., & Sawyer, M. B. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.028 · Cited by 814 · see citing works

Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis

Keating, S. E., Hackett, D. A., George, J., & Johnson, N. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.023 · Cited by 536 · see citing works

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis: Sarcopenic obesity and myosteatosis in cirrhosis

Montano-Loza, A. J., Angulo, P., Meza-Junco, J., Prado, C. M. M., Sawyer, M. B., Beaumont, C., Esfandiari, N., Ma, M., & Baracos, V. E. (2016) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12039 · Cited by 512 · see citing works

A multicenter study to define sarcopenia in patients with end-stage liver disease

Carey, E. J., Lai, J. C., Wang, C. W., Dasarathy, S., Lobach, I., Montano‐Loza, A. J., Dunn, M. A., & for the Fitness, L. E. (2017) · Liver Transplantation · doi:10.1002/lt.24750 · Cited by 498 · see citing works

Non-alcoholic fatty liver disease, obesity and the metabolic syndrome

Dietrich, P., & Hellerbrand, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.008 · Cited by 458 · see citing works

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

Koo, B. K., Kim, D., Joo, S. K., Kim, J. H., Chang, M. S., Kim, B. G., Lee, K. L., & Kim, W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.019 · Cited by 440 · see citing works

Relationship Between Sarcopenia and Nonalcoholic Fatty Liver Disease: The Korean Sarcopenic Obesity Study

Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385 · see citing works

Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis

Lee, Y., Doumouras, A. G., Yu, J., Brar, K., Banfield, L., Gmora, S., Anvari, M., & Hong, D. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.017 · Cited by 371 · see citing works

Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)

Lee, Y., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y., Lee, B., Kang, E. S., Han, K., Lee, H. C., & Soo, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 342 · see citing works

Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008‐2011)

Lee, Y., Kim, S. U., Song, K., Park, J. Y., Kim, D. Y., Ahn, S. H., Lee, B., Kang, E. S., Cha, B., & Han, K. (2015) · Hepatology · doi:10.1002/hep.28376 · Cited by 340 · see citing works

Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis

Berzigotti, A., Garcia-Tsao, G., Bosch, J., Grace, N. D., Burroughs, A. K., Morillas, R., Escorsell, A., Garcia-Pagan, J. C., Patch, D., Matloff, D. S., et al. (2011) · Hepatology · doi:10.1002/hep.24418 · Cited by 325 · see citing works

Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects

Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., et al. (2011) · Hepatology · doi:10.1002/hep.24242 · Cited by 307 · see citing works

Dynamics of the skeletal muscle secretome during myoblast differentiation

Henningsen, J., Rigbolt, K. T. G., Blagoev, B., Pedersen, B. K., & Kratchmarova, I. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.002113 · Cited by 303 · see citing works

AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions.

Lonardo, A., Nascimbeni, F., Targher, G., Bernardi, M., Bonino, F., Bugianesi, E., Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.147 · Cited by 279 · see citing works

Association of sarcopenic obesity with the risk of all‐cause mortality: A meta‐analysis of prospective cohort studies

Tian, S., & Xu, Y. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12579 · Cited by 274 · see citing works

Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis

Katsagoni, C. N., Georgoulis, M., Papatheodoridis, G. V., Panagiotakos, D. B., & Kontogianni, M. D. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.006 · Cited by 270 · see citing works

The Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report

Correa‐de‐Araujo, R., Harris‐Love, M. O., Miljkovic, I., Fragala, M. S., Anthony, B., & Manini, T. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00087 · Cited by 267 · see citing works

Adiponectin, a key adipokine in obesity related liver diseases.

Buechler, C., Wanninger, J., & Neumeier, M. (2011) · PubMed Central · doi:10.3748/wjg.v17.i23.2801 · Cited by 261 · see citing works

Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline

Mathus-Vliegen, E. M. H., Basdevant, A., Finer, N., Hainer, V., Hauner, H., Micic, D., Maislos, M., Roman, G., Schutz, Y., Tsigos, C., et al. (2012) · Obesity Facts · doi:10.1159/000341193 · Cited by 261 · see citing works

Late evening snack: exploiting a period of anabolic opportunity in cirrhosis

Tsien, C. D., McCullough, A. J., & Dasarathy, S. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06951.x · Cited by 252 · see citing works

The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease

Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225 · see citing works

Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease

Petta, S., Ciminnisi, S., Marco, V. D., Cabibi, D., Cammà, C., Licata, A., Marchesini, G., & Craxı̀, A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13889 · Cited by 217 · see citing works

Irisin in patients with nonalcoholic fatty liver disease

Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Geladari, E. V., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.013 · Cited by 215 · see citing works

Exercise-based Interventions for Nonalcoholic Fatty Liver Disease: A Meta-analysis and Meta-regression

Orci, L. A., Gariani, K., Oldani, G., Delaune, V., Morel, P., & Toso, C. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.04.036 · Cited by 213 · see citing works

Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis

Román, E. M., Torrades, M. T., Nadal, M. J., Cárdenas, G., Nieto, J. C., Vidal, S., Bascuñana, H., Juárez, C., Guarner, C., Córdoba, J., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3086-6 · Cited by 197 · see citing works

Diets and nonalcoholic fatty liver disease: The good and the bad

Asrih, M., & Jornayvaz, F. R. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.11.003 · Cited by 180 · see citing works

Sarcopenia in liver cirrhosis

Giusto, M., Lattanzi, B., Albanese, C. V., Galtieri, A., Farcomeni, A., Giannelli, V., Lucidi, C., Martino, M. D., Catalano, C., & Merli, M. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000274 · Cited by 173 · see citing works

Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway

Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158 · see citing works

Sarcopenic obesity: how do we treat it?

Bouchonville, M. F., & Villareal, D. T. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433071.11466.7f · Cited by 141 · see citing works

Body mass index in childhood and adult risk of primary liver cancer

Berentzen, T. L., Gamborg, M., Holst, C., Sørensen, T. I. A., & Baker, J. L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.015 · Cited by 138 · see citing works

Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis

Hiraoka, A., Michitaka, K., Kiguchi, D., Izumoto, H., Ueki, H., Kaneto, M., Kitahata, S., Aibiki, T., Okudaira, T., Tomida, H., et al. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000986 · Cited by 134 · see citing works

Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation

Carias, S., Castellanos, A. L., Vilchez, V., Nair, R. T., Cruz, A. C. D., Watkins, J., Barrett, T. A., Patel, T., Esser, K. A., & Gedaly, R. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13166 · Cited by 130 · see citing works

Sarcopenic obesity in cirrhosis—The confluence of 2 prognostic titans

Eslamparast, T., Montaño‐Loza, A. J., Raman, M., & Tandon, P. (2018) · Liver International · doi:10.1111/liv.13876 · Cited by 124 · see citing works

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Yu, S. J., Kim, W. K., Kim, D., Yoon, J., Lee, K., Kim, J. H., Cho, E. J., Lee, J., Kim, H. Y., Kim, Y. J., et al. (2015) · Medicine · doi:10.1097/md.0000000000002159 · Cited by 122 · see citing works

Sarcopenic obesity as an independent risk factor of hypertension

Park, S. H., Park, J. H., Song, P. S., Kim, D. K., Kim, K. H., Seol, S. H., Kim, H. K., Jang, H. J., Lee, J. G., Park, H. Y., et al. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.002 · Cited by 118 · see citing works

Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis

Hara, N., Iwasa, M., Sugimoto, R., Mifuji‐Moroka, R., Yoshikawa, K., Terasaka, E., Hattori, A., Ishidome, M., Kobayashi, Y., Hasegawa, H., et al. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5676 · Cited by 114 · see citing works

Adipokines in Liver Cirrhosis

Buechler, C., Haberl, E. M., Rein‐Fischboeck, L., & Aslanidis, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071392 · Cited by 84 · see citing works

Bariatric Surgery Outcomes in Sarcopenic Obesity

Mastino, D., Robert, M., Betry, C., Laville, M., Gouillat, C., & Disse, E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2102-7 · Cited by 79 · see citing works

Obesity, adipokines and hepatocellular carcinoma

Duan, X.-F., Tang, P., Li, Q., & Yu, Z. (2013) · International Journal of Cancer · doi:10.1002/ijc.28105 · Cited by 75 · see citing works

Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis

Pan, X., Han, Y., Zou, T., Zhu, G., Xu, K., Zheng, J.-N., Zheng, M., & Cheng, X. (2018) · Digestive Diseases · doi:10.1159/000491015 · Cited by 57 · see citing works

Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?

Merli, M., & Dasarathy, S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.014 · Cited by 51 · see citing works

Impact of obesity and insulin-resistance on cirrhosis and portal hypertension

Berzigotti, A., & Abraldeṣ, J. G. (2013) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2013.03.005 · Cited by 43 · see citing works

Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review

Tovo, C. V., Fernandes, S. A., Buss, C., & de Mattos, Â. A. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i6.326 · Cited by 42 · see citing works

Is the Adiponectin-AMPK-Mitochondrial Axis Involved in Progression of Nonalcoholic Fatty Liver Disease?

Dasarathy, S. (2014) · Hepatology · doi:10.1002/hep.27134 · Cited by 32 · see citing works

Muscle mass vs. adipose tissue to predict outcome in cirrhosis: Which matters and in which patients?

Merli, M., & Durand, F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.06.005 · Cited by 10 · see citing works

Current treatment of non‐alcoholic fatty liver disease

Paternostro, R., & Trauner, M. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13531 · Cited by 305 · see citing works

Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions

de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052639 · Cited by 189 · see citing works

Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications

Barbalho, S. M., Flato, U. A. P., Tofano, R. J., Goulart, R. D. A., Guiguer, E. L., Detregiachi, C. R. P., Buchaim, D. V., Araújo, A. C., Buchaim, R. L., Reina, F. T. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103607 · Cited by 156 · see citing works

Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025

Roeb, E., Canbay, A., Bantel, H., Bojunga, J., de Laffolie, J., Demir, M., Denzer, U., Geier, A., Hofmann, W., Hudert, C., et al. (2022) · Zeitschrift für Gastroenterologie - German Journal of Gastroenterology · doi:10.1055/a-1880-2283 · Cited by 90 · see citing works

European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline

Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.003 · Cited by 61 · see citing works

European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline

Bischoff, S. C., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Eshraghian, A., Kani, H. T., Khannoussi, W., Lacaze, L., et al. (2022) · United European Gastroenterology Journal · doi:10.1002/ueg2.12280 · Cited by 54 · see citing works

Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link

Ryu, J. Y., Choi, H. M., Yang, H.-I., & Kim, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186887 · Cited by 52 · see citing works

The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review

Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48 · see citing works

Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography

Tanaka, M., Okada, H., Hashimoto, Y., Kumagai, M., Nishimura, H., Oda, Y., & Fukui, M. (2019) · Liver International · doi:10.1111/liv.14253 · Cited by 45 · see citing works

Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score

Chang, J., Höfer, P., Böhling, N., Lingohr, P., Manekeller, S., Kalff, J. C., Dohmen, J., Kaczmarek, D. J., Jansen, C., Meyer, C. H., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100442 · Cited by 44 · see citing works

Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline

Bischoff, S. C., Ockenga, J., Eshraghian, A., Barazzoni, R., Busetto, L., Campmans-Kuijpers, M. J. E., Cardinale, V., Chermesh, I., Kani, H. T., Khannoussi, W., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.03.021 · Cited by 45 · see citing works

Association between sarcopenia and prediabetes among non-elderly US adults

Xu, J., Han, X., Chen, Q., Cai, M., Tian, J., Yan, Z., Guo, Q., Xu, J., & Lü, H. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02038-y · Cited by 32 · see citing works

Updated S2k clinical practice guideline on non-alcoholic fatty liver disease (NAFLD) issued by the German society of gastroenterology, digestive and metabolic diseases (DGVS)–April 2022–AWMF Registration No.: 021–025

Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30 · see citing works

Nonalcoholic fatty liver disease and sarcopenia: Where do we stand?

Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30 · see citing works

2,3,5,4'-tetrahydroxystilbence-2-O-β-D-glucoside attenuates hepatic steatosis via IKKβ/NF-κB and Keap1-Nrf2 pathways in larval zebrafish

Wang, C., Hu, N., Yu, L.-Y., Gong, L., Dai, X., Peng, C. Y., & Li, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110138 · Cited by 22 · see citing works

Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan

Wijarnpreecha, K., Aby, E. S., Ahmed, A., & Kim, D. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3323 · Cited by 20 · see citing works

Nutritional status and body composition in individuals with overweight or obesity using usual and unusual indicators

Christinelli, H. C. B., Westphal, G., Nardo, N., Borim, M. L. C., Costa, M. A. R., & Fernandes, C. A. M. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11339 · Cited by 17 · see citing works

Sarcopenic obesity in liver disease: Handling both sides of the penny

Hui, Y., Cui, B., Wang, X., Sun, M., Li, Y., Yang, W., Guo, G., Mao, L., Yu, Z., Fan, X., et al. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.10 · Cited by 17 · see citing works

Therapeutic effects of chitin from Pleurotus eryngii on high-fat diet induced obesity in rats

Huang, J., Zhangzhou, C., Zhangzhou, C., Zhangzhou, C., Wu, Q., Lin, Z., Liu, S., Su, Q., & Pan, Y. (2020) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.0775 · Cited by 16 · see citing works

Sarcopenia in end-stage liver disease and after liver transplantation

Leunis, S., Vandecruys, M., Craenenbroeck, A. H. V., Cornelissen, V., Bogaerts, S., Smet, S. D., & Monbaliu, D. R. L. (2023) · Acta gastro-enterologica belgica · doi:10.51821/86.2.11412 · Cited by 16 · see citing works

Identification of TRAPPC9 and BAIAP2 Gene Polymorphisms and Their Association With Fat Deposition-Related Traits in Hu Sheep

Cui, P., Wang, W., Zhang, D., Li, C., Huang, Y., Ma, Z., Wang, X., Zhao, L., Zhang, Y., Yang, X., et al. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.928375 · Cited by 15 · see citing works

Heat shock response to exercise in pancreatic islets of obese mice

Bittencourt, A., Schroeder, H. T., Porto, R. R., Muller, C. H. D. L., Krause, M. D. S., & de Bittencourt, P. I. H. (2019) · Biochimie · doi:10.1016/j.biochi.2019.10.015 · Cited by 14 · see citing works

Multi-omics reveals goose fatty liver formation from metabolic reprogramming

Wei, R., Teng, Y., Han, C., Wei, S., Li, L., Liu, H., Hu, S., Kang, B., & Xu, H. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1122904 · Cited by 12 · see citing works

Estimated Cardiorespiratory Fitness Attenuates the Impacts of Sarcopenia and Obesity on Non-Alcoholic Fatty Liver in Korean Adults

Lee, I., Kim, J., & Kang, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17113902 · Cited by 11 · see citing works

Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits

Ali, S. E., & Nguyen, M. H. (2021) · Life · doi:10.3390/life11020119 · Cited by 12 · see citing works

Influence of the nutritional status on facial morphology in young Japanese women

Tanikawa, C., Kurata, M., 谷崎典子, Takeuchi, M., Zere, E., Fukuo, K., & Takada, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-21919-5 · Cited by 10 · see citing works

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases

Nishikawa, H., Yoh, K., Enomoto, H., Nishiguchi, S., & Iijima, H. (2021) · Diagnostics · doi:10.3390/diagnostics11071262 · Cited by 10 · see citing works

Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial

Jiang, W., Huang, S., Ma, S., Gong, Y., Fu, Z., Zhou, L. Q., Hu, W., Mao, G., Ma, Z., Yang, L., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-020-00511-6 · Cited by 10 · see citing works

Integrative analysis of transcriptome and lipidome reveals fructose pro-steatosis mechanism in goose fatty liver

Wei, R., Han, C., Wei, S., Teng, Y., Li, L., Liu, H., Hu, S., Kang, B., & Xu, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1052600 · Cited by 9 · see citing works

Frontiers and hotspots of adipose tissue and NAFLD: a bibliometric analysis from 2002 to 2022

Gu, S., Qiao, Y., Liu, S.-S., Yang, S., Cong, S.-B., Wang, S.-Q., Yu, D., Wang, W., & Chai, X.-L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1278952 · Cited by 9 · see citing works

Efficacy of Probiotic Strains Lactobacillus sakei Probio65 and Lactobacillus plantarum Probio-093 in Management of Obesity: An In Vitro and In Vivo Analysis

Gulnaz, A., Lew, L.-C., Park, Y.-H., Sabir, J. S. M., Albiheyri, R. S., Rather, I. A., & Hor, Y.-Y. (2024) · Pharmaceuticals · doi:10.3390/ph17060676 · Cited by 8 · see citing works

Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH)

El‐Sherif, O., & Armstrong, M. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1697616 · Cited by 8 · see citing works

Nutrition in Chronic Liver Disease

Reddy, Y. K., Maliakkal, B. J., & Agbim, U. A. (2019) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-019-00252-3 · Cited by 8 · see citing works

A Comparison Study on the Therapeutic Effect of High Protein Diets Based on Pork Protein versus Soybean Protein on Obese Mice

Jiang, S., Ji, S., Tang, X., Wang, T., Wang, H., & Meng, X. (2022) · Foods · doi:10.3390/foods11091227 · Cited by 7 · see citing works

Fructose intake is not associated to the risk of hepatic fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Azevedo, V. Z., & Dall’Alba, V. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.022 · Cited by 7 · see citing works

Enhancing the Hypolipidemic and Functional Properties of Flammulina velutipes Root Dietary Fiber via Steam Explosion

Ma, C., Ni, L., Sun, M., Hu, F., Guo, Z., Zeng, H., Sun, W., Zhang, M., Wu, M., & Zheng, B. (2024) · Foods · doi:10.3390/foods13223621 · Cited by 6 · see citing works

Sarcopenic obesity at the crossroad of pathogenesis of cardiometabolic diseases

Guaraldi, G., Milić, J., Sebastiani, G., & Raggi, P. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.006 · Cited by 6 · see citing works

Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study

Kumbaroğlu, F. B., Balaban, Y. H., & Düger, T. (2025) · Medicina · doi:10.3390/medicina61020247 · Cited by 5 · see citing works

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study

Tomiyama, T., Harada, N., Toshima, T., Nakayama, Y., Toshida, K., Morinaga, A., Kosai‐Fujimoto, Y., Tomino, T., Kurihara, T., Takeishi, K., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10723 · Cited by 4 · see citing works

Analyzing body composition in living kidney donors: impact on post-transplant kidney function

Quint, E. E., Westenberg, L. B., Nieuwenhuijs‐Moeke, G. J., van den Broek, E. A. N., Zorgdrager, M., Viddeleer, A. R., Bakker, S. J. L., Nolte, I. M., van Londen, M., Pol, R. A., et al. (2024) · Frontiers in Nephrology · doi:10.3389/fneph.2024.1467669 · Cited by 3 · see citing works

Sarcopenia as a Risk Factor for Mortality in NAFLD : How Should We Diagnose It?

Stankevicius, C., Davis, R. H., Huynh, D. K., Hatzi, M., Morgillo, S., & Day, A. S. (2024) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13329 · Cited by 2 · see citing works

Relationship between skeletal muscle mass loss and metabolic dysfunction-associated fatty liver disease among Chinese patients with metabolic dysregulation

Xu, M., Lin, Y., Yang, N., Li, J., Li, L., Ding, H., & Xu, C. (2024) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20230963 · Cited by 1 · see citing works

Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review

Ye, T., Mi, K., Zhu, L., Li, J. C., & Pan, C. Q. (2024) · Obesity Facts · doi:10.1159/000541650 · Cited by 1 · see citing works

Therapeutic effects of chitin from Pleurotus eryngii on high-fat diet induced obesity in rats [pdf]

Huang, J., Zhangzhou, C., Zhangzhou, C., Zhangzhou, C., Wu, Q., Lin, Z., Liu, S., Su, Q., & Pan, Y. (2020) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.2020.0775

Causal and mediating link between sarcopenia and nonalcoholic fatty liver disease: A bidirectional two-sample, two-step Mendelian randomization study

Li, Y., Feng, W., Sun, X., & Dong, Y. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104207

Additional file 1 of Effectiveness of companion-intensive multi-aspect weight management in Chinese adults with obesity: a 6-month multicenter randomized clinical trial

Jiang, W., Huang, S., Ma, S., Gong, Y., Fu, Z., Zhou, L., Hu, W., Mao, G., Ma, Z., Yang, L., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13710529

Mise au point d’un nouvel outil diagnostique de l’obésité sarcopénique : relations avec la dysfonction du tissu adipeux, l’insulinorésistance et la sévérité de l’atteinte hépatique

Azevedo, V. Z. (2024) · theses.fr (ABES) · doi:10.70675/6f7a5047ze3eaz482fzaae4zb7f1dc7abc0a

Sarcopenia and fatty liver disease

Kim, J. A., & Choi, K. M. (2019) · Hepatology International · doi:10.1007/s12072-019-09996-7 · Cited by 127 · see citing works

Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease—The Union of Two Culprits

Ali, S. E., & Nguyen, M. H. (2021) · Life · doi:10.3390/life11020119 · Cited by 12 · see citing works

Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease

Azevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 59 · see citing works

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis

Song, W., Yoo, S. H., Jang, J., Baik, S. J., Lee, B. K., Lee, H. W., & Park, J. S. (2022) · Gut and Liver · doi:10.5009/gnl220041 · Cited by 30 · see citing works

Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease

Iwaki, M., Kobayashi, T., Nogami, A., Saito, S., Nakajima, A., & Yoneda, M. (2023) · Nutrients · doi:10.3390/nu15040891 · Cited by 61 · see citing works